Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial



Status:Recruiting
Conditions:Renal Impairment / Chronic Kidney Disease, Hospital
Therapuetic Areas:Nephrology / Urology, Other
Healthy:No
Age Range:18 - Any
Updated:9/21/2018
Start Date:December 2015
End Date:July 2019
Contact:Chad Bailey, MD
Email:cbailey@ucdavis.edu

Use our guide to learn which trials are right for you!

Incisional negative pressure therapy (INPWT) has previously been shown in certain patient
populations to decrease wound healing complications, decrease the rate of hematomas and
seromas, as well as have better scar quality. We have found a group of patients, those who
have panniculectomies in preparation for renal transplant, with significantly higher rates of
wound healing complications. We believe the best way to demonstrate benefits of incisional
negative pressure wound therapy will be in this group of patients known to have significantly
higher rates of wound complications.


Inclusion Criteria:

- All patients undergoing panniculectomy in preparation for renal transplantation at the
University of California Davis Medical Center. Patients who are entered into the trial
and have 30 days of follow up, and those in the INPWT study arm who successfully
complete 7 days of treatment, will be included.

Exclusion Criteria:

- All patients who previously demonstrated a hypersensitivity reaction to adhesives and
qualify for panniculectomy in preparation for renal transplantation, or all patients
who are undergoing panniculectomy for reasons other than in preparation for renal
transplantation (i.e. after massive weight loss or for cosmetic reasons). Patients who
do not complete the duration of treatment of negative pressure wound therapy (7 days),
or patients who do not follow up for a minimum of 30 days from the date of surgery
will be excluded. Adults unable to consent, infants, children, teenagers, pregnant
patients and prisoners will be excluded. It is also extremely unlikely, based on our
study population, that we will encounter any of these patients.
We found this trial at
1
site
2315 Stockton Blvd.
Sacramento, California 95817
(916) 734-2011
University of California, Davis Medical Center UC Davis Medical Center serves a 65,000-square-mile area that...
?
mi
from
Sacramento, CA
Click here to add this to my saved trials